Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2019-06-19 2019-05-14
Drug Identification Number 02310945 02310945
Brand name PRO-NAPROXEN EC - 375 PRO-NAPROXEN EC - 375
Common or Proper name PRO-NAPROXEN EC - 375 PRO-NAPROXEN EC - 375
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients NAPROXEN NAPROXEN
Strength(s) 375MG 375MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-11-15 2019-11-29
Actual discontinuation date
Remaining supply date 2020-02-29 2020-02-29
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments